Semler Scientific gets 185 bitcoins, increasing total holdings to 4,449 BTC
Today, Semler Scientific announced that it has increased its Bitcoin holdings. Using proceeds from its AT-The-Market (ATM) issuance program, the company acquired 185 bitcoins for $20 million between May 23 and June 3, with an average purchase price per bitcoin of $107,974.
“We continue to use operating cash flows to value Bitcoin Arsenal and earn from debt and equity financing,” said Semler Scientific Eric Semler Chairman. “We are pleased to launch the Semler Scientific dashboard today on our website to provide the public with regular updates on Bitcoin Holdings and other key metrics.”
Since the launch of the ATM program in April 2025, Semler has raised approximately $136.2 million in common stock under sales agreements.
As of June 3, 2025, Semler held 4,449 bitcoins, with the purchase price of $410 million and the average purchase price is $92,158 per bitcoin. At the time of writing, these holdings have a market value of approximately $446.2 million.
Eric Semler on X released: “SMLR acquired 185 bitcoins for $20 million and generated a BTC yield of 26.7%. Now holds $4,449 in BTC.”
Semler Scientific uses BTC output as a key performance indicator (KPI) to help evaluate its performance in obtaining Bitcoin strategies. As of year to date, the company’s BTC yield is 26.7%.
“Semler Scientific believes that this KPI can be used to supplement investors’ understanding of Semler Scientific’s decision to buy Bitcoin by issuing additional shares of its common stock or tools that can be converted into common stock,” Form 8-K said.
In the first quarter of 2025, Semler Scientific reported a tough quarter. Revenue was $8.8 million, down 44% year-on-year. Operating expenses jumped to $39.9 million last year, mainly due to the possible $29.8 million in connection with the potential Justice Department settlement. This resulted in $31.1 million in operating losses, compared with $7 million in Q1 2024 profit.
“Our healthcare business is a green shoot from the cardiovascular product line introduced to the large enterprise customer base this year,” said Semler Scientific Doug Murphy-Chutorian CEO. “We expect these FDA cleared products and services will grow and cash, which will increase our Bitcoin treasury strategy.”
